LOS ANGELES, Nov. 03, 2016 (GLOBE NEWSWIRE) -- The Workgroup for Electronic Data Interchange (WEDI) is the leading authority on the use of information technology to improve healthcare information exchange. Its goal is to enhance quality of care, improve efficiency, and reduce costs within the American healthcare system. RadNet (NASDAQ:RDNT) today announced that it will lead a presentation at WEDI-Con 2016 near Washington, DC.
RadNet is a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, as well as related radiology solutions. RadNet will focus its remarks on the impact of the Medicare Access and CHIP Reauthorization Act (MACRA), the most recent—and sweeping—pay-for-performance legislation passed by the Centers for Medicare and Medicaid Services (CMS).
At WEDI-Con 2016, Susan Hollabaugh, RadNet’s Senior Director of Clinical Solutions and Interoperability, will present alongside Stanley Nachimson, principal of Nachimson Advisors and the former CMS lead on regulatory development and implementation of the Health Insurance Portability and Accountability Act (HIPAA). Nachimson will outline the proposed requirements of MACRA, and Hollabaugh will focus on how RadNet addresses the challenges providers may face during implementation.
As the largest imaging center network in the U.S., RadNet brings a unique perspective to regulatory issues and their impact on providers. “RadNet has a complex environment because of our broad range of services,” Hollabaugh said. “New or changed rules have a significant effect on our business, and we prepare extensively and in advance for those changes. Both regulators and providers can learn from our experience.”
MACRA, which scores physician groups across four categories and replaces existing programs such as Meaningful Use (MU) and the Physician Quality Reporting System (PQRS), is due to begin its first reporting period on January 1, 2017.
“We were involved in fact-finding before CMS even published the proposed rule. We spent a year gearing up,” said Hollabaugh, “and we provided feedback to CMS on what we thought would be important for MACRA.”
As part of that preparation, RadNet leveraged its participation with many industry organizations, such as the American College of Radiology (ACR), Radiology Business Management Association (RBMA), the Imaging e-Ordering Coalition and CMS itself. “We are working with ACR and their clinical data repository to meet both the quality report and clinical practice improvement requirements,” Hollabaugh said.
Ranjan Jayanathan, RadNet’s Chief Information Officer, said: “As a radiology leader, we’re committed to improving national healthcare. The principles inherent in these regulations are important priorities for RadNet. We’re happy to contribute the expertise we’ve gained as a national provider and hope it will foster greater gains for everyone involved.”
Details for RadNet’s Presentation:
|Date:||Tuesday, November 8, 2016|
|Time:||1:50 p.m. Eastern Time|
|Location:||Hyatt Regency, Reston, VA|
RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of more than 310 owned and/or operated outpatient imaging centers. RadNet’s core markets include California, Maryland, Delaware, New Jersey, New York, Florida and Rhode Island. In addition, RadNet provides radiology information technology solutions, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has more than 7,500 employees. For more information, visit http://www.radnet.com.
Last updated on: 03/11/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.